The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation
about
European guidance for the diagnosis and management of osteoporosis in postmenopausal womenVenous thromboembolic diseaseEstradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and betaTamoxifen: catalyst for the change to targeted therapyOsteoporosis and its managementTamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancerTransforming growth factors-beta are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system.Breast cancer preventionA new day dawns: women without oestrogen or is a balance best?Endogenous hormones and the aetiology of breast cancer.Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer.Hormonal control of p53 and chemopreventionFuture possibilities in the prevention of breast cancer: breast cancer prevention trials.Future possibilities in the prevention of breast cancer: fat and fiber and breast cancer researchFuture possibilities in the prevention of breast cancer: role of genetic variation in breast cancer prevention.Oestrogen exposure and breast cancer riskAdvances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapyTowards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormonesEndocrinology and hormone therapy in breast cancer: selective oestrogen receptor modulators and downregulators for breast cancer - have they lost their way?Tamoxifen may prevent both ER+ and ER- breast cancers and select for ER- carcinogenesis: an alternative hypothesis.Selective Estrogen Receptor ModulatorsNew insights into treatment of osteoporosis in postmenopausal womenThe evolution of selective estrogen receptor modulators in osteoporosis therapyThe discovery and development of selective estrogen receptor modulators (SERMs) for clinical practiceMain controversies in breast cancerThe 2.0 Å crystal structure of the ERα ligand-binding domain complexed with lasofoxifeneBreast cancer chemoprevention: progress and controversy.Breast cancer chemoprevention: old and new approachesThe epidemiology and management of postmenopausal osteoporosis: a viewpoint from BrazilMedical prevention of breast cancerFamiliar drugs may prevent cancerProfile of V. Craig JordanChemoprevention of breast cancer. A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast CancerStructure-function relationships of the raloxifene-estrogen receptor-alpha complex for regulating transforming growth factor-alpha expression in breast cancer cellsRheumatology: 15. OsteoporosisDoes raloxifene reduce risk of vertebral fractures? Is this another, brighter way to treat osteoporosis?Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancerEvaluating the potential bioactivity of a novel compound ER1626
P2860
Q24612411-4E81AAA0-EF25-4130-B24E-06D65A281B49Q24631121-B7C30412-7441-4C19-8ED4-5FE29AEDB25AQ24632806-14143573-8F32-4211-917B-A6718B402880Q24652988-E5331793-BB3D-4725-921C-D67BC0863BD8Q24670075-F842FAB7-E72E-4B14-814D-E481470B66F7Q24670339-80D2EC0E-A0F6-4BDA-9583-66F84BEBB02CQ24791032-8D9F33EB-7C99-417B-B21B-0A5D10A28495Q24797803-2E53C9AF-39EF-4D44-9829-66CD4BD41186Q24800226-11186B17-BC7B-4C12-B7DF-887973244073Q24800587-B75E1C69-A52C-4CE6-8CFA-2588E2DDB512Q24800731-ED77AE3F-F71A-4FF8-9BDB-E5B890B4144AQ24802454-4802E3D7-2F24-4062-BD2C-928E02B6B495Q24803259-CA884C2F-CFB4-483F-A465-64F9D1A23793Q24803306-AC9BBF9A-A037-4044-BAB9-CF3DA34726DDQ24803327-0E38FFE5-08B1-41D8-BCED-4D3AF2B1F45AQ24803498-63A74AC2-814A-4DE1-8C05-AADF52EA3EEAQ24803990-3C5B7661-80E4-482D-B7DB-E0B65A1769DFQ24806501-F3E94A88-BC08-4DF6-A6C3-8982A5D6B7EFQ24810287-8C82CD48-226C-4964-8B60-257A6A5F8F32Q25257858-8D4BC95B-0499-4A33-95FC-2F2731DF98C7Q26738923-06D82DF6-E4BC-4BDC-B4FE-E9C268453468Q26777910-35473793-2A7A-4AB0-838D-3D72A6BD66B2Q26827973-E732793D-609D-4ADB-B14D-68D2E09F44DAQ26830744-638C8007-1340-4B48-9BFE-DC890FDB45A7Q27026673-D5CF6662-290D-4315-A12A-8BBFEC449CEAQ27644597-FD53E299-EC5C-4582-A63F-91C0BDB68E2FQ27692587-22BE4855-ECAF-4433-A303-D86FDAC12E4DQ27693259-A5951565-B126-4E44-B6EC-A9441EA43CC6Q28080673-EF313D15-480C-4458-9458-86C569A1BB9BQ28086915-004ED2E3-832D-40E2-8CE2-7339F170A3BFQ28186835-B9D8AEDE-F139-4809-8B56-6155D28AE676Q28253151-3B7E6D32-8FC5-4879-9B69-DEF76C8A4284Q28343780-72F79CA1-2E9D-4F8C-829C-A756E2D60DB1Q28343990-30998E79-4C2D-4CCA-A19A-8B2148E6BB5DQ28344803-9D80B77F-CD7D-4FFD-95CD-5E4F3BF57EA0Q28365306-B1DD5B53-7718-4B62-857D-46826A1CEAFBQ28366565-6C2FFBCA-5A9C-4E96-B56A-C8BB2B7BD8BCQ28539181-34A94F9B-E20F-46EC-9865-C749D41EFF09
P2860
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The effect of raloxifene on ri ...... comes of Raloxifene Evaluation
@ast
The effect of raloxifene on ri ...... comes of Raloxifene Evaluation
@en
The effect of raloxifene on ri ...... comes of Raloxifene Evaluation
@nl
type
label
The effect of raloxifene on ri ...... comes of Raloxifene Evaluation
@ast
The effect of raloxifene on ri ...... comes of Raloxifene Evaluation
@en
The effect of raloxifene on ri ...... comes of Raloxifene Evaluation
@nl
prefLabel
The effect of raloxifene on ri ...... comes of Raloxifene Evaluation
@ast
The effect of raloxifene on ri ...... comes of Raloxifene Evaluation
@en
The effect of raloxifene on ri ...... comes of Raloxifene Evaluation
@nl
P2093
P1476
The effect of raloxifene on ri ...... comes of Raloxifene Evaluation
@en
P2093
J A Cauley
J E Glusman
K A Krueger
M E Lippman
N H Bjarnason
P304
P407
P50
P577
1999-06-16T00:00:00Z